LONG-TERM CLINICAL OUTCOME AFTER PRIMARY STENTING FOR SUBCLAVIAN ARTERY DISEASE  by Yusuke, Tomoi et al.
Vascular Disease
E2115
JACC March 27, 2012
Volume 59, Issue 13
LONG-TERM CLINICAL OUTCOME AFTER PRIMARY STENTING FOR SUBCLAVIAN ARTERY DISEASE
ACC Moderated Poster Contributions
McCormick Place South, Hall A
Saturday, March 24, 2012, 11:00 a.m.-Noon
Session Title: Endovascular Therapy: State of the Science II
Abstract Category: 35. Peripheral Arterial/Carotid Disease/Aortic Disease
Presentation Number: 1122-136
Authors: Tomoi Yusuke, Yoshimitsu Soga, Masashi Iwabuchi, Kokura Memorial Hospital, Kitakyushu, Japan
Background: Little is known about long-term clinical outcomes after endovascular therapy (EVT) for subclavian artery disease (SCD). The aim of 
this study was to investigate the long-term clinical outcome after primary stenting for SCD.
Methods: From January 2001 to December 2010, 83 patients (34% female, 69.9±8.6 years old, 86% left subclavian disease,) underwent 
successful primary stenting for de novo SCD. Mean lesion length was 27.9±12.7mm, chronic total occlusion was included in 27%. Outcome 
measures were primary and secondary patency and all-cause mortality for SCD. Primary patency was defined as treated vessel without restenosis 
(defined as >2.5 of peak systolic velocity ratio by duplex) and repeat revascularization. Secondary patency was defined as target vessel which 
subsequently become totally occluded and is reopened by repeat revascularization. Initial success was defined as <30% of residual stenosis without 
complications. Complication was included that emergency operation, cerebral infarction, myocardial infarction, aortic dissection and rupture, and 
puncture site troubles, prolonged hospitalization for any reasons.
Result: The mean follow-up interval was 48 (±34) months. Initial success was achieved in 93% and complication rate was 8%. Primary patency at 
1- and 3- and 5-year were 97%, 91% and 85%, respectively. Secondary patency was 100% during follow-up period. On multivariate analysis, female 
gender (p=0.02), and vertebral artery stenosis (P<0.01), were independent predictors of primary patency. Overall survival rates were 90%, 79%, 
68% at 1- and 3- and 5-years. Cardiovascular mortality was 54%, infectious diseases (severe sepsis, aspiration pneumonia) mortality was 16%. On 
multivariate analysis, age (P=0.02), chronic kidney disease (P=0.003), dialysis (P=0.004), were independent predictors of all cause mortality.
Conclusion: Primary stenting for SCD was safety and was effective for the long-termclinicalfollow-up period.
